NO20045111L - Metabolsk fenotyping - Google Patents

Metabolsk fenotyping

Info

Publication number
NO20045111L
NO20045111L NO20045111A NO20045111A NO20045111L NO 20045111 L NO20045111 L NO 20045111L NO 20045111 A NO20045111 A NO 20045111A NO 20045111 A NO20045111 A NO 20045111A NO 20045111 L NO20045111 L NO 20045111L
Authority
NO
Norway
Prior art keywords
subjects
dosing
dose
post
subject
Prior art date
Application number
NO20045111A
Other languages
English (en)
Inventor
Jeremy Kirk Nicholson
Thomas Andrew Clayton
Jeremy Ramsey Everett
John Christopher Lindon
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0213786A external-priority patent/GB0213786D0/en
Priority claimed from GB0213895A external-priority patent/GB0213895D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of NO20045111L publication Critical patent/NO20045111L/no

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5038Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites per se

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Saccharide Compounds (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medical Treatment And Welfare Office Work (AREA)

Abstract

Fremgangsmåte for å generere modeller med hvilke en kan karakterisere utvalgte aspekter av den metabolske fenotypen for subjekter uten å dosere en testsubstans til disse subjektene eller med hvilke en kan predikere, uten dosering, post-dose responsene for subjekter hvor disse responsene er avhengig av metabolsk fenotype, hvor fremgangsmåten omfatter: oppnå pre-dose data som relaterer til en pluralitet av subjekter før dosering med en doseringssubstans; oppnå post-dose data som relaterer til pluraliteten av subjekter etter dosering med doseringssubstansen; og korrelere inter-subjektvariasjon i pre-dose dataene med inter-subjektvariasjon i post-dose-dataene, og generere en pre-til-post dose prediktiv modell på grunnlag av den observerte korrelasjonen. Modellene kan anvendes for å bestemme utvalgte aspekter av den metabolske fenotypen for et subjekt eller for å predikere, uten dosering, post-dose responsene for subjekter. Dette oppnås ved å analysere data som relaterer til det ikke-doserte subjektet i relasjon til en modell som beskriver korrelasjonen av pre-dose og post-dose-data som relaterer til en pluralitet av subjekter når dosert med en bestemt substans som provoserer den biokjemiske omdanningen eller overføringsbanen ("pathway) av interesse; og generere, i henhold til de prebestemte kriteriene for modellen, et numerisk mål eller klassifikasjon som beskiver den metabolske fenotypen av/for det ikke-doserte subjektet.
NO20045111A 2002-06-14 2004-11-24 Metabolsk fenotyping NO20045111L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0213786A GB0213786D0 (en) 2002-06-14 2002-06-14 Metabolic phenotyping
GB0213895A GB0213895D0 (en) 2002-06-17 2002-06-17 Metabolic phenotyping
PCT/IB2003/002309 WO2003107270A2 (en) 2002-06-14 2003-06-16 Metabolic phenotyping

Publications (1)

Publication Number Publication Date
NO20045111L true NO20045111L (no) 2005-01-12

Family

ID=29738094

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20045111A NO20045111L (no) 2002-06-14 2004-11-24 Metabolsk fenotyping

Country Status (15)

Country Link
US (2) US20050074745A1 (no)
EP (1) EP1540560B1 (no)
JP (1) JP4829496B2 (no)
KR (1) KR20050012281A (no)
AT (1) ATE502343T1 (no)
AU (1) AU2003232406A1 (no)
CA (1) CA2487836C (no)
DE (1) DE60336403D1 (no)
HK (1) HK1080167A1 (no)
HR (1) HRP20041174A2 (no)
IL (1) IL165329A0 (no)
IN (1) IN2004DN03762A (no)
NO (1) NO20045111L (no)
RU (1) RU2004136317A (no)
WO (1) WO2003107270A2 (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050037515A1 (en) * 2001-04-23 2005-02-17 Nicholson Jeremy Kirk Methods for analysis of spectral data and their applications osteoporosis
US20040142496A1 (en) * 2001-04-23 2004-07-22 Nicholson Jeremy Kirk Methods for analysis of spectral data and their applications: atherosclerosis/coronary heart disease
US8068987B2 (en) * 2001-08-13 2011-11-29 Bg Medicine, Inc. Method and system for profiling biological systems
EP1540560B1 (en) 2002-06-14 2011-03-16 Pfizer Limited Metabolic phenotyping
EP1665108A2 (en) * 2003-08-20 2006-06-07 BG Medicine, Inc. Methods and systems for profiling biological systems
WO2007050940A2 (en) * 2005-10-27 2007-05-03 Brandon Horn Method for determining metabolic type
US7899625B2 (en) * 2006-07-27 2011-03-01 International Business Machines Corporation Method and system for robust classification strategy for cancer detection from mass spectrometry data
JP5363984B2 (ja) * 2006-10-13 2013-12-11 メタボロン インコーポレイテッド 代謝年齢に関するバイオマーカー及びその使用方法
US20080286774A1 (en) * 2007-05-16 2008-11-20 The Regents Of The University Of California Real-time individualized therapy evaluation
US20100273203A1 (en) * 2009-04-23 2010-10-28 Board Of Trustees Of The University Of Arkansas Methods and compositions for detecting metabolites
US8660823B2 (en) * 2009-04-26 2014-02-25 Lester F. Ludwig Nonlinear and lie algebra structural analysis system for enzyme cascades, metabolic signal transduction, signaling pathways, catalytic chemical reaction networks, and immunology
GB0912744D0 (en) 2009-07-22 2009-08-26 Imp Innovations Ltd Methods and uses
GB0912685D0 (en) 2009-07-22 2009-08-26 Imp Innovations Ltd Methods
US8410064B2 (en) * 2009-08-24 2013-04-02 The Board Of Trustees Of The University Of Arkansas Classical cannabinoid metabolites and methods of use thereof
US8883218B2 (en) 2010-03-26 2014-11-11 The Board Of Trustees Of The University Of Arkansas Anti-cancer nanoparticle compositions and methods of use
GB201012297D0 (en) * 2010-07-22 2010-09-08 Ge Healthcare Uk Ltd A system and method for automated biological cell assay data analysis
WO2012018535A2 (en) * 2010-07-26 2012-02-09 Wellness Indicators, Inc. Wellness panel
US9095598B2 (en) 2010-12-28 2015-08-04 The Board Of Trustees Of The University Of Arkansas Stilbenoid derivatives and their uses
US9535144B2 (en) * 2012-06-01 2017-01-03 Liposcience, Inc. NMR quantification of TMAO
US9361429B2 (en) 2012-06-08 2016-06-07 Liposcience, Inc. Multi-parameter diabetes risk evaluations
US9928345B2 (en) 2012-06-08 2018-03-27 Liposciences, Inc. Multiple-marker risk parameters predictive of conversion to diabetes
US9470771B2 (en) 2012-06-08 2016-10-18 Liposcience, Inc. NMR measurements of NMR biomarker GlycA
RU2533846C1 (ru) * 2013-05-13 2014-11-20 Сергей Леонидович Устьянцев Способ определения энтропии в организме человека или животного
CN104215623B (zh) * 2013-05-31 2018-09-25 欧普图斯(苏州)光学纳米科技有限公司 面向多行业检测的激光拉曼光谱智能化辨识方法及系统
US9953417B2 (en) 2013-10-04 2018-04-24 The University Of Manchester Biomarker method
US9519823B2 (en) * 2013-10-04 2016-12-13 The University Of Manchester Biomarker method
CN107764848A (zh) * 2016-08-18 2018-03-06 中国科学院烟台海岸带研究所 一种基于代谢组学评价石斑鱼饲料利用的方法
CN108766587B (zh) * 2018-05-11 2022-05-03 北京诺道认知医学科技有限公司 一种基于指定药物构建给药数据库的方法及装置
CN108717876B (zh) * 2018-05-11 2022-05-20 大连诺道认知医学技术有限公司 一种基于指定药物构建给药数据库的方法及装置
CN108445112B (zh) * 2018-05-29 2021-03-16 云南中烟工业有限责任公司 一种烟叶烟气中4-(n-甲基-n-亚硝胺)-1-(3-吡啶基)-丁酮的检测方法
WO2020081326A1 (en) * 2018-10-15 2020-04-23 Olaris, Inc. Spectographic metabolite-signature for identifying a subject's susceptibility to drugs
EP4042224A4 (en) * 2019-10-10 2023-11-08 Georgia Tech Research Corporation LABEL-FREE HEMATOLOGICAL AND HISTOPATHOLOGICAL ANALYSIS USING UV MICROSCOPY

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6658396B1 (en) * 1999-11-29 2003-12-02 Tang Sharon S Neural network drug dosage estimation
AU2001278075A1 (en) * 2000-07-28 2002-02-13 Lion Bioscience Ag Pharmacokinetic tool and method for predicting metabolism of a compound in a mammal
EP1540560B1 (en) 2002-06-14 2011-03-16 Pfizer Limited Metabolic phenotyping

Also Published As

Publication number Publication date
HRP20041174A2 (en) 2005-06-30
AU2003232406A1 (en) 2003-12-31
JP4829496B2 (ja) 2011-12-07
IN2004DN03762A (no) 2010-01-08
RU2004136317A (ru) 2006-01-27
CA2487836A1 (en) 2003-12-24
US20050074745A1 (en) 2005-04-07
EP1540560B1 (en) 2011-03-16
WO2003107270A3 (en) 2005-04-21
CA2487836C (en) 2014-12-02
EP1540560A2 (en) 2005-06-15
US8577617B2 (en) 2013-11-05
IL165329A0 (en) 2006-01-15
HK1080167A1 (zh) 2006-04-21
KR20050012281A (ko) 2005-01-31
WO2003107270A2 (en) 2003-12-24
US20090192721A1 (en) 2009-07-30
ATE502343T1 (de) 2011-04-15
JP2005534899A (ja) 2005-11-17
DE60336403D1 (de) 2011-04-28

Similar Documents

Publication Publication Date Title
HK1080167A1 (zh) 代謝表型化
BRPI0507858A (pt) arrasto suave para teste de pressão de formação
Kelloway et al. Longitudinal research and data analysis
WO2011042448A3 (en) Managing flow testing and the results thereof for hydrocarbon wells
GB0617451D0 (no)
ATE431097T1 (de) Verfahren und vorrichtung für die analyse einer flüssigkeit
WO2006133149A3 (en) Method for analyzing power consumption of circuit design using hardware emulation
GB2468045A (en) Method for reservoir characterization and monitoring including deep reading quad combo measurements
RU2008144430A (ru) Способ и система получения косметических средств на заказ
WO2007020598A3 (en) Method and apparatus featuring simple click style interactions according to a clinical task workflow
CN109918833A (zh) 一种数值模拟可信度的定量分析方法
Welty et al. Metrology for AI: From benchmarks to instruments
BR122017010425B8 (pt) método de produzir uma medição de um analito usando uma tira de teste
GB201015230D0 (en) A method and system for managing analytical quality in networked laboratories
Klauenberg et al. Bayesian glaciological modelling to quantify uncertainties in ice core chronologies
WO2008129561A3 (en) Real-time system and method for designing structures
Savić et al. Metrological traceability of a system for measuring electrodermal activity
FI20031778A (fi) Menetelmä, mittalaite, tietokoneohjelma ja järjestelmä palautteen antamiseksi käyttäjälle toiminnan aikana
GB2437023A (en) A method and apparatus for checking in situ the calibration of a device for measuring the value of a variable property
CN107942733A (zh) 模型测试系统
Moritz et al. Test methods in the development of sports equipment
Fiebig Recent developments in the standardization of soundscape
Cui et al. Application of artificial intelligence wearable technology in the big data analysis of physical activity in China
Walker Estimating how many observations are needed to obtain a required level of reliability
Auld Statistical modelling of environmental extremes

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application